(Q40088374)

English

Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.

scientific article published on 28 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B. (English)

1 reference

Europe PubMed Central

17 September 2017

0 references

author name string

Tetsuro Baba

1

1 reference

Europe PubMed Central

17 September 2017

Takeshi Hanagiri

2

1 reference

Europe PubMed Central

17 September 2017

Yoshinobu Ichiki

3

1 reference

Europe PubMed Central

17 September 2017

Koji Kuroda

4

1 reference

Europe PubMed Central

17 September 2017

Yoshiki Shigematsu

5

1 reference

Europe PubMed Central

17 September 2017

Makiko Mizukami

6

1 reference

Europe PubMed Central

17 September 2017

Masakazu Sugaya

7

1 reference

Europe PubMed Central

17 September 2017

Mitsuhiro Takenoyama

8

1 reference

Europe PubMed Central

17 September 2017

Kenji Sugio

9

1 reference

Europe PubMed Central

17 September 2017

Kosei Yasumoto

10

1 reference

Europe PubMed Central

17 September 2017

publication date

28 August 2007

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

98

1 reference

Europe PubMed Central

17 September 2017

1795-1802

1 reference

Europe PubMed Central

17 September 2017

11

1 reference

Europe PubMed Central

17 September 2017

Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Cellular ligands of activating NK receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

A method to identify cDNAs based on localization of green fluorescent protein fusion products

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Different checkpoints in human NK-cell activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Identifying and overcoming immune resistance mechanisms in the melanoma tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00586.X

21 January 2018

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Identifiers

10.1111/J.1349-7006.2007.00586.X

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40088374&oldid=837412017"